Healthcare provider profile · identity verified

Marc H Michelson, DO

Internal Medicine · TURNERSVILLE, NJ · NPI 1063404861

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	341	97
Atorvastatin Calcium	Atorvastatin Calcium	258	80
Amlodipine Besylate	Amlodipine Besylate	250	81
Alprazolam	Alprazolam	231	66
Losartan Potassium	Losartan Potassium	201	56
Pantoprazole Sodium	Pantoprazole Sodium	153	51
Simvastatin	Simvastatin	150	44
Rosuvastatin Calcium	Rosuvastatin Calcium	146	48
Metoprolol Succinate	Metoprolol Succinate	143	49
Tramadol Hcl	Tramadol Hcl	124	20
Metformin Hcl	Metformin Hcl	118	34
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	116	18
Hydrochlorothiazide	Hydrochlorothiazide	107	29
Omeprazole	Omeprazole	100	34
Clonazepam	Clonazepam	88	19
Famotidine	Famotidine	87	32
Montelukast Sodium	Montelukast Sodium	81	28
Furosemide	Furosemide	80	25
Lorazepam	Lorazepam	78	25
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	74	suppressed
Lisinopril	Lisinopril	73	29
Trazodone Hcl	Trazodone Hcl	71	20
Allopurinol	Allopurinol	67	19
Azithromycin	Azithromycin	64	41
Gabapentin	Gabapentin	64	22
Carvedilol	Carvedilol	63	18
Zolpidem Tartrate	Zolpidem Tartrate	59	16
Eliquis	Apixaban	58	16
Fluticasone Propionate	Fluticasone Propionate	58	28
Clonidine Hcl	Clonidine Hcl	57	suppressed
Diclofenac Sodium	Diclofenac Sodium	51	12
Duloxetine Hcl	Duloxetine Hcl	50	19
Pravastatin Sodium	Pravastatin Sodium	50	18
Glimepiride	Glimepiride	48	18
Tamsulosin Hcl	Tamsulosin Hcl	48	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	13
Fenofibrate	Fenofibrate Nanocrystallized	45	12
Meloxicam	Meloxicam	42	12
Oxycodone Hcl	Oxycodone Hcl	42	15
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	40	11
Esomeprazole Magnesium	Esomeprazole Magnesium	39	14
Ibuprofen	Ibuprofen	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	17
Jardiance	Empagliflozin	35	suppressed
Sertraline Hcl	Sertraline Hcl	35	12
Cefuroxime	Cefuroxime Axetil	34	23
Finasteride	Finasteride	34	suppressed
Valsartan	Valsartan	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	25
Temazepam	Temazepam	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Methylprednisolone	Methylprednisolone	31	22
Prednisone	Prednisone	31	16
Synthroid	Levothyroxine Sodium	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	20
Ozempic	Semaglutide	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Fentanyl	Fentanyl	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Diazepam	Diazepam	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Pregabalin	Pregabalin	18	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Atenolol	Atenolol	16	suppressed
Baclofen	Baclofen	16	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Topiramate	Topiramate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Glipizide	Glipizide	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Naproxen	Naproxen	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydrocodone-Ibuprofen	Hydrocodone/Ibuprofen	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Nexium	Esomeprazole Magnesium	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error